Expansion of ambulatory care is central to St. Louis-based Ascension’s growth strategy, particularly through the planned acquisition of AmSurg, according to financial documents published May 15. The health system is poised to become one of the largest ASC operators in the country by acquiring AmSurg and its 250 ASCs for $3 billion. While the deal was initially expected to close in late 2025 or early 2026, the filing confirmed it remains pending, noting “the transaction is expected to be finalized after all necessary approvals are obtained.”
Read the full article: Ascension’s $3B AmSurg Deal Still Pending — Here’s What’s at Stake //
Source: https://www.beckersasc.com/asc-transactions-and-valuation-issues/ascensions-3b-amsurg-deal-still-pending-heres-whats-at-stake/